PROQR THERAPEUTICS EO-04 Net Asset Quality Index
PROQR THERAPEUTICS EO-04 net asset quality index. PROQR THERAPEUTICS EO-04 (0PQ) has a Net Asset Quality Index of 43.8% as of December 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of €112.76 Million minus total liabilities of €63.38 Million yields net assets of €49.37 Million. A higher index indicates a stronger, lower-leverage balance sheet. See PROQR THERAPEUTICS EO-04 shareholders equity for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of PROQR THERAPEUTICS EO-04 (2021–2025)
Net asset quality index of PROQR THERAPEUTICS EO-04 from 2021 to 2025. This chart shows how PROQR THERAPEUTICS EO-04's Net Asset Quality Index has evolved across 5 annual periods from 2021 to 2025. As of December 2025, the index stands at 43.8%, representing net assets of €49.37 Million against total assets of €112.76 Million EUR. Check asset allocation strategy of PROQR THERAPEUTICS EO-04 to assess the company's strategic physical and investment asset allocation.
PROQR THERAPEUTICS EO-04 Net Asset Quality Index by Year (2021–2025)
PROQR THERAPEUTICS EO-04 net asset quality index by year from 2021 to 2025. The table below presents the year-by-year Net Asset Quality Index for PROQR THERAPEUTICS EO-04 from 2021 to 2025, covering 5 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see PROQR THERAPEUTICS EO-04 (0PQ) market capitalisation.
| Year | Quality Index | Net Assets (EUR) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 43.8% | €49.37 Million | €112.76 Million | €63.38 Million | ▼ -8.9 pp |
| 2024 | 52.7% | €88.56 Million | €167.96 Million | €79.40 Million | ▲ +22.7 pp |
| 2023 | 30.0% | €41.39 Million | €137.88 Million | €96.49 Million | ▼ -8.9 pp |
| 2022 | 38.9% | €66.68 Million | €171.32 Million | €104.64 Million | ▼ -15.1 pp |
| 2021 | 54.0% | €113.23 Million | €209.58 Million | €96.35 Million | — |